Highlights Sernova Corp. OTC Markets

Equities

SEOVF

CA81732W1041

Market Closed - OTC Markets Other stock markets 18:30:32 17/07/2024 BST			5-day change	1st Jan Change
0.215 ^USD	-1.22%		+2.38%	-59.65%

07-15	Sernova Corp. Appoints Jonathan Rigby as Executive Chairman	CI
06-14	Sernova Corp. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sernova Corp. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024	06-14	CI
Sernova Corp. Appoints Jonathan Rigby to Board of Directors	05-28	CI
Sernova Corp. Provides Positive Clinical and Platform Portfolio Update	04-02	CI
Sernova Corp. Reports Earnings Results for the First Quarter Ended January 31, 2024	03-18	CI
Sernova Corp. Reports Earnings Results for the Full Year Ended October 31, 2023	01-29	CI
Sernova Receives Orphan Drug and Rare Pediatric Disease Designations for its Hemophilia A Program from FDA	11-27	MT
Sernova Corp. Announces New Advancements of Conformal Coating Technology in Combination with the Cell Pouch System? at the 2023 IPITA-IXA-CTRMS Joint Congress	30/10/23	CI
Sernova Announces Positive Ongoing Interim Phase 1/2 Clinical Data for the Cell Pouch System? for Type 1 Diabetes Trial at the 2023 IPITA, IXA, and CTRMS Joint Congress	27/10/23	CI
Sernova Corp. Announces New Preclinical Data for its Novel Cell Therapy Platform, Cell Pouch System, as Potential Treatment for Post-Operative Hypothyroidism at 2023 American Thyroid Association Annual Meeting	29/09/23	CI
Sernova Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	12/09/23	CI
Sernova Corp. Provides Development Update on Proprietary Cellular Conformal Coating Technology in Combination with Cell Pouch Device	07/09/23	CI
Sernova Corp Appoints Modestus Obochi as Chief Business Officer	26/07/23	CI
Sernova Corp. Reports Updated Interim Phase 1/2 Clinical Data for Cell Pouch System at American Diabetes Association Meet	26/06/23	MT
Sernova Corp. Brief: Announcing "Positive" Updated Interim Phase 1/2 Clinical Data for the Cell Pouch System at American Diabetes Association 83rd Scientific Sessions	26/06/23	MT
Sernova Corp. Announces Positive Updated Interim Phase 1/2 Clinical Data for the Cell Pouch Systemâ„¢? at American Diabetes Association 83rd Scientific Sessions	26/06/23	CI
Sernova Corp. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	14/06/23	CI
Toronto Stocks Flat After Tuesday's Decline; Loblaw Shares Slide as 1Q Profit Falls, Revenue Misses	03/05/23	DJ
AstraZeneca Teams Up With Sernova to Develop Therapeutic Cell Technologies	03/05/23	MT
Sernova Corp. Announces Research Collaboration with AstraZeneca to Evaluate Novel Potential Therapeutic Cell Applications	03/05/23	CI
Sernova Corp. Announces the Presentation of Preclinical Data	24/04/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Sernova Corp. OTC Markets

Equities

SEOVF

CA81732W1041

Highlights

Filters